- Home
- SCOR vs AKTX Comparison
SCOR vs AKTX Comparison
Compare SCOR & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- AKTX
- Stock Information
- Founded
- SCOR 1999
- AKTX N/A
- Country
- SCOR United States
- AKTX United States
- Employees
- SCOR N/A
- AKTX N/A
- Industry
- SCOR Business Services
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- SCOR Consumer Discretionary
- AKTX Health Care
- Exchange
- SCOR Nasdaq
- AKTX Nasdaq
- Market Cap
- SCOR 27.7M
- AKTX 29.1M
- IPO Year
- SCOR 2007
- AKTX N/A
- Fundamental
- Price
- SCOR $5.50
- AKTX $1.46
- Analyst Decision
- SCOR Buy
- AKTX
- Analyst Count
- SCOR 2
- AKTX 0
- Target Price
- SCOR $10.75
- AKTX N/A
- AVG Volume (30 Days)
- SCOR 8.8K
- AKTX 27.1K
- Earning Date
- SCOR 05-06-2025
- AKTX 04-16-2025
- Dividend Yield
- SCOR N/A
- AKTX N/A
- EPS Growth
- SCOR N/A
- AKTX N/A
- EPS
- SCOR N/A
- AKTX N/A
- Revenue
- SCOR $356,047,000.00
- AKTX N/A
- Revenue This Year
- SCOR $4.38
- AKTX N/A
- Revenue Next Year
- SCOR $3.97
- AKTX N/A
- P/E Ratio
- SCOR N/A
- AKTX N/A
- Revenue Growth
- SCOR N/A
- AKTX N/A
- 52 Week Low
- SCOR $4.59
- AKTX $0.85
- 52 Week High
- SCOR $15.69
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- SCOR 46.17
- AKTX 64.33
- Support Level
- SCOR $4.59
- AKTX $1.03
- Resistance Level
- SCOR $5.63
- AKTX $1.58
- Average True Range (ATR)
- SCOR 0.61
- AKTX 0.15
- MACD
- SCOR -0.01
- AKTX 0.03
- Stochastic Oscillator
- SCOR 53.22
- AKTX 78.95
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).